AGC Appoints New CFO
V. Ashok has been appointed as ACG's new group chief financial officer.
AGC, supplier of fully integrated solutions to the pharma and nutraceutical industries, has appointed a new group chief financial officer. It was revealed in a July 5, 2021 press release that V. Ashok has taken on the new role.
Ashok’s experience includes management of global investors, improving business performance, business planning, acquisitions, and building future-fit governance mechanisms. Previously, Ashok held positions with the Liberty Group in London, Essar Group, and Majan Glass Company Muscat.
“We are delighted to welcome Ashok to the ACG family,” saidKaran Singh, MD, ACG, in the press release. “His rich experience in leading the financial operations of industrial businesses will prove to be valuable in the next stages of ACG’s drive towards a healthier tomorrow. I am confident Ashok will provide strong leadership and will be an excellent addition to the ACG team.”
Ashok added, in the press release, “ACG is an innovative and exciting company to join, and a pivotal organization in the pharma manufacturing sector. I look forward to playing an integral part in the next stage of expansion/growth and working with a world-class team.”
Source: ACG
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
